Migovib-SR 40 Tablet
By Migovib
Rx
10 Tablet SR in a Strip

Composition
Propranolol(40mg)

Manufacturer - Vibcare Pharma Pvt Ltd
Plot No 4, HSIIDC IT PARK,Sector 22, Panchkula, Haryana 134109

Expires on or after
October, 2025
About Migovib-SR 40 Tablet
Migovib-SR 40 Tablet is a medication that helps in reducing anxiety and alleviating tremors. In addition to this, it is prescribed for the prevention of migraines, angina (heart-related chest pain), and bleeding in the stomach resulting from elevated blood pressure in the liver (portal hypertension). Moreover, Migovib-SR 40 Tablet can also be used in the treatment of high blood pressure and certain types of abnormal heart rhythms (arrhythmia).
The appropriate dosage of Migovib-SR 40 Tablet varies depending on the condition being treated and individual response to the medication. It is essential to follow the doctor's instructions precisely. The tablet should be taken on an empty stomach at approximately the same time each day to maximize its effectiveness. Even if a person feels better, it is important to continue taking the medication as directed. Abruptly discontinuing Migovib-SR 40 Tablet can lead to the worsening of the condition.
Common side effects of Migovib-SR 40 Tablet include fatigue, weakness, Raynaud phenomenon (cold fingers and toes), irregular or slow heartbeat, numbness in the fingers, and shortness of breath. Nausea, vomiting, and diarrhea are also possible side effects. If these side effects persist or become bothersome, it is advisable to consult with a healthcare provider. Typically, most side effects are temporary and tend to improve as the body adjusts to the medication.
Individuals with asthma, very slow or irregular heartbeats, serious heart conditions such as heart failure, kidney or liver issues, or chronic obstructive pulmonary disease (COPD) should avoid using Migovib-SR 40 Tablet without consulting a doctor. Additionally, the consumption of alcohol can impact the efficacy of this medication and should be avoided. It is also recommended not to drive if the medication induces dizziness. Pregnant or breastfeeding individuals should seek medical advice before initiating Migovib-SR 40 Tablet to determine its safety.
Benefits
Migovib-SR 40 Tablet offers various benefits for different health conditions. Firstly, in the prevention of angina, this medication relaxes the blood vessels, allowing better blood flow throughout the body and ensuring that the heart receives an adequate supply of oxygen. By reducing the frequency of angina attacks, it can improve exercise tolerance and daily activities, making it easier to lead a normal life.
Secondly, for arrhythmia treatment, Migovib-SR 40 Tablet helps stabilize heart rate and normalize abnormal heart rhythms, thereby preventing episodes or slowing down the heart rate during an occurrence.
Moreover, when used for the prevention of heart attacks, this medication helps lower blood pressure, making it easier for the heart to pump blood effectively and reducing the risk of a heart attack. Prompt administration of Migovib-SR 40 Tablet after a heart attack can also decrease the likelihood of death.
In cases of hypertension, Migovib-SR 40 Tablet relaxes blood vessels, effectively lowering blood pressure and subsequently reducing the risk of stroke, heart attack, or kidney problems in the long term. While its benefits may not be immediately felt, consistent use as prescribed can significantly contribute to overall well-being.
Furthermore, Migovib-SR 40 Tablet aids in the treatment of anxiety by preventing the release of chemicals in the brain that cause anxiety symptoms, such as restlessness, tiredness, and sleep problems. It can improve daily functioning and productivity, allowing individuals to manage their activities more comfortably.
Additionally, for tremor treatment, this medication enhances blood flow and prevents abnormal muscle activity that triggers tremors, thereby improving daily functionality and quality of life.
Lastly, in migraine prevention, Migovib-SR 40 Tablet enhances blood flow in the brain and prevents muscle activity that triggers migraines. By reducing the frequency of migraine attacks, it can help individuals carry out daily activities and improve their overall quality of life.
In conclusion, Migovib-SR 40 Tablet offers a range of benefits across various conditions, highlighting its effectiveness in managing cardiovascular issues, anxiety, tremors, and migraines, ultimately contributing to improved quality of life and overall well-being.
How to use the Migovib-SR 40 Tablet
To use Migovib-SR 40 Tablet effectively, follow your doctor's instructions on the dosage and duration of the medication. It's important to swallow the tablet whole with water, without chewing, crushing, or breaking it. Remember to take Migovib-SR 40 Tablet on an empty stomach for best results.
It's suggested to avoid high-fat meals like olive oil, nuts & seeds (such as Brazil nuts), dark chocolate, butter, and meat when taking Migovib-SR 40 Tablet to ensure its optimal effectiveness. By adhering to these guidelines, you can maximize the benefits of this medication and manage your condition more effectively.
Uses of Migovib-SR 40 Tablet
Migovib-SR 40 Tablet is a versatile medication with various important uses. It is commonly utilized for preventing angina which is heart-related chest pain. Additionally, it is effective in treating arrhythmia, a condition characterized by an irregular heart rhythm. This tablet is also beneficial in preventing heart attacks and managing hypertension, a common condition of high blood pressure. Furthermore, Migovib-SR 40 Tablet is helpful in the treatment of anxiety, tremors, and migraine prevention. It can also be used in the treatment of pheochromocytoma. By addressing high blood pressure, chest pain, heart rhythm disorders, and anxiety, this medication plays a crucial role in maintaining cardiovascular health and overall well-being.
What conditions Migovib-SR 40 Tablet treats?
Migovib-SR 40 Tablet is commonly used to manage high blood pressure, a chronic condition characterized by elevated pressure in the arteries as the heart pumps blood. High blood pressure can lead to complications such as heart attack, stroke, and kidney failure due to reduced blood and oxygen flow to vital organs. Monitoring blood pressure regularly is crucial, with ideal readings between 90/60 mm Hg and 120/80 mm Hg. The tablet can help regulate blood pressure and prevent associated health risks.
Should you consult a doctor?
It is important to seek the advice of a doctor when taking Migovib-SR 40 Tablet. If you experience persistent side effects such as tiredness, weakness, irregular heartbeat, numbness, breathlessness, nausea, vomiting, diarrhea, or cold fingers and toes, it is recommended to consult with your healthcare provider. Additionally, if you have concerns about any side effects or if they worsen over time, it is crucial to seek medical attention.
Furthermore, if you have underlying health conditions such as asthma, heart problems, kidney or liver issues, or COPD, it is advisable to consult your doctor before starting this medication. Pregnant or breastfeeding individuals should also seek medical guidance before using Migovib-SR 40 Tablet. In case you notice any significant changes in your overall health or if you have questions about the medicine, do not hesitate to reach out to your healthcare provider for professional advice.
Side effects of Migovib-SR 40 Tablet
When taking Migovib-SR 40 Tablet, you may experience some side effects. Most side effects are usually mild and temporary as your body gets used to the medication. However, if any of the following side effects persist or become concerning, it is important to consult your doctor. Some common side effects of Migovib-SR 40 Tablet include cold extremities, sleep disturbances, fatigue, slow heart rate, and nightmares.
Other possible side effects that may occur while using Migovib-SR 40 Tablet include headaches, feeling tired, dizzy or weak, cold fingers or toes, nausea or vomiting, diarrhea, and stomach pain. It is essential to monitor these side effects and seek medical advice if needed. If you have any concerns about the side effects or if they worsen over time, consult your healthcare provider for further guidance.
Safety advice

liver
When using Migovib-SR 40 Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment when taking this medication. It is advisable to consult your doctor before starting or adjusting the dosage of Migovib-SR 40 Tablet to ensure it is safe for your liver condition.

kidney
Migovib-SR 40 Tablet needs caution in severe kidney disease. Dose adjustment might be necessary. Consult your doctor.

alcohol
It is unsafe to consume alcohol with Migovib-SR 40 Tablet.

driving
When taking Migovib-SR 40 Tablet, be cautious while driving. Blood sugar levels can impact your driving abilities. Avoid driving if you experience low or high blood sugar symptoms.

pregnancy
Migovib-SR 40 Tablet may not be safe to use during pregnancy. Limited human studies suggest potential harm to the developing baby, as indicated by animal studies. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor.

breastfeeding
Migovib-SR 40 Tablet may not be safe to use while breastfeeding. Limited information suggests a possible risk of the drug passing into breastmilk and causing harm to the baby.
Consumption warning before consuming Migovib-SR 40 Tablet
Before consuming Migovib-SR 40 Tablet, there are several important warnings to consider. Firstly, avoid using this medication if you are in a state of cardiogenic shock or have heart failure. It is crucial not to abruptly stop taking Migovib-SR 40 Tablet without consulting your doctor, as sudden discontinuation can lead to heart rhythm disturbances, blood pressure fluctuations, chest pain, or even a heart attack. To prevent these risks, your doctor will gradually reduce your dosage over time. Individuals with a slow heartbeat, asthma, sick sinus syndrome, any heart blockage, or children weighing less than 4.5 pounds should not use this medication. Additionally, do not administer this drug to children under 12 years old. Inform your doctor about any muscle disorders, breathing issues, low blood sugar, low blood pressure, depression, previous heart failure, liver or kidney problems, thyroid disorders, adrenal gland cancer, circulation problems, or if you have diabetes type 1 or type 2. It is advised not to discontinue Migovib-SR 40 Tablet usage before any surgery, as it may mask diabetes symptoms and exacerbate heart failure and bradycardia. Regular monitoring of prothrombin time is essential if taking this medication with anticoagulants like warfarin.
Disease interactions
When it comes to Migovib-SR 40 Tablet, it is crucial to be aware of certain medical conditions that might interact with this medication. People with diabetes, thyroid disease, asthma, cardiogenic shock (a condition where the heart fails to pump enough blood), heart valve problems, low blood pressure (hypotension), coronary heart disease, liver disease, or heart failure should avoid taking Migovib-SR 40 Tablet. It is important to consult with a healthcare provider before using this medication if you have any of these conditions to prevent any potential adverse effects.
What if you forgot to take Migovib-SR 40 Tablet?
If you forget to take your Migovib-SR 40 Tablet, try to take it as soon as you remember. But if it's nearly time for your next scheduled dose, it's best to skip the missed one and continue with your regular dosing schedule. It is important not to take a double dose to make up for the missed one. By taking the missed dose as soon as possible or following your regular dosing routine, you can help maintain the effectiveness of your treatment regimen.
Related lab tests
For individuals taking Migovib-SR 40 Tablet, it is advisable to undergo regular kidney function tests. These tests provide essential information about how well the kidneys are working and can help monitor any potential side effects of the medication on kidney function. The specific lab tests that are recommended include serum creatinine test, blood urea nitrogen (BUN) test, glomerular filtration rate (GFR) test, and urine albumin test. These tests evaluate different aspects of kidney function such as filtration rate, waste removal, and protein levels in the urine. Regular monitoring of kidney function through these lab tests can help healthcare providers ensure the safety and effectiveness of treatment with Migovib-SR 40 Tablet.
Additional Information
Habit Forming | No |
Chemical Class | Naphthalene Derivative |
Therapeutic Class | CARDIAC |
Action Class | - |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹27
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 18-Nov-2024